New drug KESONOTIDE™ enters human trials for multiple cancers
Disease control
Recruiting now
This study tests a new drug, KESONOTIDE™, in people with advanced solid tumors like prostate, breast, lung, ovarian, brain, pancreas, or skin cancer. The trial has two phases: first, finding the safest dose, then testing that dose in a larger group. About 80 participants will be …
Phase: PHASE1, PHASE2 • Sponsor: Filamon LTD • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC